Journal of Experimental Medicine, Vol 173, 147-158, Copyright © 1991 by Rockefeller University Press

ARTICLES

Epstein-Barr virus (EBV)-associated lymphoproliferative disease in the SCID mouse model: implications for the pathogenesis of EBV-positive lymphomas in man

M Rowe, LS Young, J Crocker, H Stokes, S Henderson and AB Rickinson
Department of Cancer Studies, University of Birmingham Medical School, United Kingdom.

When human peripheral blood lymphocytes (PBLs) from Epstein-Barr virus (EBV)-seropositive donors are injected intraperitoneally into SCID mice, EBV+ B cell tumors develop within weeks. A preliminary report (Mosier, D. E., R. J. Gulizia, S. M. Baird, D. D. Richman, D. B. Wilson, R. I. Fox, and T. J. Kipps, 1989. Blood. 74(Suppl. 1):52a) has suggested that such tumors resemble the EBV-positive malignancy, Burkitt's lymphoma. The present work shows that generally the human (hu) PBL-SCID tumors are distinct from Burkitt's lymphoma and instead resemble lymphoblastoid cell lines (LCLs) generated by EBV-infection of normal B cells in vitro in terms of: (a) their cell surface phenotype, with expression of B cell activation antigens and adhesion molecules, (b) normal karyotype, and (c) viral phenotype, with expression of all the transformation-associated EBV latent proteins and, in a minority of cells, productive cycle antigens. Indeed, in vitro-transformed LCLs also grow when inoculated into SCID mice, the frequency of tumor outgrowth correlating with the in vitro growth phenotype of the LCL which is itself determined by the identity of the transforming virus (i.e., type 1 or type 2 EBV). Histologically the PBL-derived hu-SCID tumors resemble the EBV+ large cell lymphomas that develop in immuno- suppressed patients and, like the human tumors, often present at multiple sites as individual monoclonal or oligoclonal foci. The remarkable efficiency of tumor development in the hu-SCID model suggests that lymphomagenesis involves direct outgrowth of EBV- transformed B cells without requirement for secondary genetic changes, and that selection on the basis of cell growth rate alone is sufficient to explain the monoclonal/oligoclonal nature of tumor foci. EBV+ large cell lymphoma of the immunosuppressed may arise in a similar way.
CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

• Zou, P., Kawada, J., Pesnicak, L., Cohen, J. I. (2007). Bortezomib Induces Apoptosis of Epstein-Barr Virus (EBV)-Transformed B Cells and Prolongs Survival of Mice Inoculated with EBV-Transformed B Cells. J. Virol. 81: 10029-10036 [Abstract] [Full Text]  
• Keller, S. A., Hernandez-Hopkins, D., Vider, J., Ponomarev, V., Hyjek, E., Schattner, E. J., Cesarman, E. (2006). NF-{kappa}B is essential for the progression of KSHV- and EBV-infected lymphomas in vivo. Blood 107: 3295-3302 [Abstract] [Full Text]  
• Hong, G. K., Kumar, P., Wang, L., Damania, B., Gulley, M. L., Delecluse, H.-J., Polverini, P. J., Kenney, S. C. (2005). Epstein-Barr Virus Lytic Infection Is Required for Efficient Production of the Angiogenesis Factor Vascular Endothelial Growth Factor in Lymphoblastoid Cell Lines. J. Virol. 79: 13984-13992 [Abstract] [Full Text]  
• Hong, G. K., Gulley, M. L., Feng, W.-H., Delecluse, H.-J., Holley-Guthrie, E., Kenney, S. C. (2005). Epstein-Barr Virus Lytic Infection Contributes to Lymphoproliferative Disease in a SCID Mouse Model. J. Virol. 79: 13993-14003 [Abstract] [Full Text]  
• May, K. F. Jr, Roychowdhury, S., Bhatt, D., Kocak, E., Bai, X.-F., Liu, J.-Q., Ferketich, A. K., Martin, E. W. Jr, Caligiuri, M. A., Zheng, P., Liu, Y. (2005). Anti-human CTLA-4 monoclonal antibody promotes T-cell expansion and immunity in a hu-PBL-SCID model: a new method for preclinical screening of costimulatory monoclonal antibodies. Blood 105: 1114-1120 [Abstract] [Full Text]  
• Katano, H., Pesnicak, L., Cohen, J. I. (2004). Simvastatin induces apoptosis of Epstein-Barr virus (EBV)-transformed lymphoblastoid cell lines and delays development of EBV lymphomas. Proc. Natl. Acad. Sci. USA 101: 4960-4965 [Abstract] [Full Text]  
• Nepomuceno, R. R., Balatoni, C. E., Natkunam, Y., Snow, A. L., Krams, S. M., Martinez, O. M. (2003). Rapamycin Inhibits the Interleukin 10 Signal Transduction Pathway and the Growth of Epstein Barr Virus B-cell Lymphomas. Cancer Res. 63: 4472-4480 [Abstract] [Full Text]  
• Loomis, R., Carbone, R., Reiss, M., Lacy, J. (2003). Bcl-2 Antisense (G3139, Genasense) Enhances the in Vitro and in Vivo Response of Epstein-Barr Virus-associated Lymphoproliferative Disease to Rituximab. Clin. Cancer Res. 9: 1931-1939 [Abstract] [Full Text]  
• van Esser, J. W. J., Niesters, H. G. M., van der Holt, B., Meijer, E., Osterhaus, A. D. M. E., Gratama, J. W., Verdonck, L. F., Lowenberg, B., Cornelissen, J. J. (2002). Prevention of Epstein-Barr virus-lymphoproliferative disease by molecular monitoring and preemptive rituximab in high-risk patients after allogeneic stem cell transplantation. Blood 99: 4364-4369 [Abstract] [Full Text]  
• Kish, T. M., Budgeon, L. R., Welsh, P. A., Howett, M. K. (2001). Immunological Characterization of Human Vaginal Xenografts in Immunocompromised Mice : Development of a Small Animal Model for the Study of Human Immunodeficiency Virus-1 Infection. Am. J. Pathol. 159: 2331-2345 [Abstract] [Full Text]  
• Nikiforow, S., Bottomly, K., Miller, G. (2001). CD4+ T-Cell Effectors Inhibit Epstein-Barr Virus-Induced B-Cell Proliferation. J. Virol. 75: 3740-3752 [Abstract] [Full Text]  
• Huang, C. A., Fuchimoto, Y., Gleit, Z. L., Ericsson, T., Griesemer, A., Scheier-Dolberg, R., Melendy, E., Kitamura, H., Fishman, J. A., Ferry, J. A., Harris, N. L., Patience, C., Sachs, D. H. (2001). Posttransplantation lymphoproliferative disease in miniature swine after allogeneic hematopoietic cell transplantation: similarity to human PTLD and association with a porcine gammaherpesvirus. Blood 97: 1467-1473 [Abstract] [Full Text]  
• Cho, A. S., Holland, G. N., Glasgow, B. J., Isenberg, S. J., George, B. L., McDiarmid, S. V. (2001). Ocular Involvement in Patients With Posttransplant Lymphoproliferative Disorder. Arch Ophthalmol 119: 183-189 [Abstract] [Full Text]  
• Young, L S, Dawson, C W, Eliopoulos, A G (2000). The expression and function of Epstein-Barr virus encoded latent genes. Mol. Pathol. 53: 238-247 [Abstract] [Full Text]  
• Guinness, M. E., Kenney, J. L., Reiss, M., Lacy, J. (2000). Bcl-2 Antisense Oligodeoxynucleotide Therapy of Epstein-Barr Virus-associated Lymphoproliferative Disease in Severe Combined Immunodeficient Mice. Cancer Res. 60: 5354-5358 [Abstract] [Full Text]  
• Wagar, E. J., Cromwell, M. A., Shultz, L. D., Woda, B. A., Sullivan, J. L., Hesselton, R. M., Greiner, D. L. (2000). Regulation of Human Cell Engraftment and Development of EBV-Related Lymphoproliferative Disorders in Hu-PBL-scid Mice. J. Immunol. 165: 518-527 [Abstract] [Full Text]  
• Sun, Q., Pollok, K. E., Burton, R. L., Dai, L. J., Britt, W., Emanuel, D. J., Lucas, K. G. (1999). Simultaneous Ex Vivo Expansion of Cytomegalovirus and Epstein-Barr Virus-Specific Cytotoxic T Lymphocytes Using B-Lymphoblastoid Cell Lines Expressing Cytomegalovirus pp65. Blood 94: 3242-3250 [Abstract] [Full Text]  
• El Mansouri, S., Martin, A., Mercadier, A., Capoulade, C., Maréchal, V., Wiels, J., Feuillard, J., Raphaël, M. (1999). High Expression of MDM2 Protein and Low Rate of p21WAF1/CIP1 Expression in SCID Mice Epstein Barr Virus-induced Lymphoproliferation. J. Histochem. Cytochem. 47: 1315-1322 [Abstract] [Full Text]  
• Benkerrou, M., Jais, J.-P., Leblond, V., Durandy, A., Sutton, L., Bordigoni, P., Garnier, J. L., Le Bidois, J., Le Deist, F., Blanche, S., Fischer, A. (1998). Anti-B-Cell Monoclonal Antibody Treatment of Severe Posttransplant B-Lymphoproliferative Disorder: Prognostic Factors and Long-Term Outcome. Blood 92: 3137-3147 [Abstract] [Full Text]  
• Donze, H. H., Cummins, J. E. Jr., Schwiebert, R. S., Fultz, P. N., Jackson, S., Mestecky, J. (1998). Human and Nonhuman Primate Lymphocytes Engrafted into SCID Mice Reside in Unique Mesenteric Lymphoid Structures. J. Immunol. 161: 1306-1312 [Abstract] [Full Text]  
• Coppola, V., Veronesi, A., Indraccolo, S., Calderazzo, F., Mion, M., Minuzzo, S., Esposito, G., Mauro, D., Silvestri, B., Gallo, P., Falagiani, P., Amadori, A., Chieco-Bianchi, L. (1998). Lymphoproliferative Disease in Human Peripheral Blood Mononuclear Cell-Injected SCID Mice. IV. Differential Activation of Human Th1 and Th2 Lymphocytes and Influence of the Atopic Status on Lymphoma Development. J. Immunol. 160: 2514-2522 [Abstract] [Full Text]  
• Moses, A., Nelson, J., Bagby, G. C. Jr (1998). The Influence of Human Immunodeficiency Virus-1 on Hematopoiesis. Blood 91: 1479-1495 [Full Text]  
• Baiocchi, R. A., Khatri, V. P., Lindemann, M. J., Ross, M. E., Papoff, G., Caprio, A. J., Caprio, T. V., Fenstermaker, R., Ruberti, G., Bernstein, Z. P., Caligiuri, M. A. (1997). Phenotypic and Functional Analysis of Fas (CD95) Expression in Primary Central Nervous System Lymphoma of Patients With Acquired Immunodeficiency Syndrome. Blood 90: 1737-1746 [Abstract] [Full Text]  
• Ometto, L., Menin, C., Masiero, S., Bonaldi, L., Del Mistro, A., Cattelan, A. M., D'Andrea, E., De Rossi, A., Chieco-Bianchi, L. (1997). Molecular Profile of Epstein-Barr Virus in Human Immunodeficiency Virus Type 1-Related Lymphadenopathies and Lymphomas. Blood 90: 313-322 [Abstract] [Full Text]  
• Sing, A. P., Ambinder, R. F., Hong, D. J., Jensen, M., Batten, W., Petersdorf, E., Greenberg, P. D. (1997). Isolation of Epstein-Barr Virus (EBV)-Specific Cytotoxic T Lymphocytes That Lyse Reed-Sternberg Cells: Implications for Immune-Mediated Therapy of EBV+ Hodgkin's Disease. Blood 89: 1978-1986 [Abstract] [Full Text]  
• Sixbey, J., Yao, Q. (1992). Immunoglobulin A-induced shift of Epstein-Barr virus tissue tropism. Science 255: 1578-1580 [Abstract]  

Home | Help | Feedback | Subscriptions | Archive | Search

TABLE OF CONTENTS